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Abstract  
AIM: Highlighting the impact of obesity on mental and cognitive functions using serum ceramide 
kinase enzyme concentration as a biomarker for cognitive evaluation in the middle aged females, 
and also targeting to control the obesity and simultaneously postponing the deterioration of the 
cognitive functions, by implementing two slimming dietary therapies each incorporating different 
functional ingredients known to boost cognition. 
SUBJECTS AND METHODS: Ninety six obese middle aged females, divided into two groups 
volunteered to follow a low caloric balanced diet combined with two bread supplements composed 
essentially of barley flour and wheat germ mixed with either 5% turmeric, group (A); or with 5% 
ginger, group (B) for 4 weeks, phase (1); to be followed by the hypocaloric diet alone for another 4 
weeks, phase (2). 
RESULTS: By the end of phase (1), the biochemical analysis showed a positive response of the 
levels of C-peptide and modified homeostatic model assessment of insulin resistance; also 
increased levels of the serum ceramide kinase enzyme, coupled with improved cognitive functions 
tests. Improvement of the relevant metabolic profile, fasting blood glucose, blood pressure and the 
anthropometric measurements was detected. 
CONCLUSION: Using dietary therapy supported by special formulas which contain active 
ingredients succeeded in reducing weight and improving both the metabolic profile and the 
cognitive functions. 
   
 
 
 
Introduction 
 
There is a direct relationship between middle 
age body weight and the risk of developing dementia 
later in life, with increased risk for the obese [1]. 
Dementia is a syndrome characterized by gradual 
decline in cognitive abilities and neuropsychiatric 
symptoms. Dementia can affect memory, language, 
attention, judgment, planning, behavior, mood and 
personality. Mild cognitive impairment does not 
significantly impair daily activities, but often represents 
an earlier stage of cognitive decline [2]. 
There is no cure for the cognitive decline and 
dementia; a cure may only be achieved by prevention. 
Dementia cases are potentially attributable to seven 
risk factors: diabetes, midlife hypertension, midlife 
obesity, depression, physical inactivity, smoking and 
cognitive inactivity [3]. Brookmeyer et al. [4] further 
estimated that 3 million cases could be prevented 
worldwide by reducing the incidence of these risk 
factors by 25%.                                                                                                                                                                                         
Insulin resistance and excess insulin resulting 
as a consequence of obesity may play a role in 
reducing beta amyloid (Aβ) clearance from the brain, 
increasing the risk of dementia and Alzheimer disease 
(AD). Adipose tissue produces proteins and hormones 
that are related to excess insulin and inflammation 
that in turn have effects on the brain. Obesity is also 
associated with increased risk for high blood pressure, 
diabetes, cardiovascular disease and cerebrovascular 
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disease, which affect brain health and increase the 
risk of dementia. Reviews of studies in this area have 
concluded that high midlife cholesterol increases the 
risk of later developing dementia by around 2 times 
[5]. Inflammation is known to play a role in the 
pathological brain changes and brain cell death that 
cause dementia [6, 7]. Therefore, several studies 
have investigated whether inflammatory biomarkers 
as C- reactive protein are associated with increased 
risk of dementia, and the potential for anti-
inflammatory drugs to reduce the risk. It has been 
suggested that the improved glucose tolerance 
observed in the presence of thiazolidinediones or 
statins is likely related to their anti-inflammatory 
properties. Thus, it can be considered that obesity 
corresponds to a sub-clinical inflammatory condition 
that promotes the production of pro-inflammatory 
factors involved in the pathogenesis of insulin 
resistance [8]. 
Ceramides and related molecules are critical 
agents involved in the pathogenesis of mild cognitive 
impairment (MCI) or early Alzheimer’s-type 
neurodegeneration disease states. They can be 
generated in liver, adipose tissue or brain; cause 
insulin resistance. They are cytotoxic; increase in the 
central nervous system (CNS) with various dementia-
associated diseases, including AD. They are lipid 
soluble, and therefore likely to readily cross the blood-
brain barrier [9]. In mammalian cells, cermide-1-
phosphate (C1P) is produced via the ATP-dependent 
mechanism of converting ceramide to C1P by the 
enzyme; ceramide kinase (CERK). CERK was first 
described as a calcium-stimulated lipid kinase that co-
purified with brain synaptic vesicles, and to date, 
CERK is the only identified mammalian enzyme 
known to produce C1P in cells [10]. Many studies 
have shown that C1P is important for membrane 
biology and for the regulation of membrane-bound 
proteins, and the CERK enzyme has appeared to be 
tightly regulated in order to control both ceramide 
levels and production of C1P [11]. 
Diet, exercise and other aspects of our daily 
interactions with the environment have the potential to 
alter our brain health and mental function. It is now 
known that particular nutrients influence cognition by 
acting on molecular systems or cellular processes that 
are vital for maintaining cognitive function. This raises 
the exciting possibility that dietary manipulations are a 
viable strategy for enhancing cognitive abilities and 
protecting the brain from damage, promoting repair 
and counteracting the effects of aging [12]. 
The aim of this work was to highlight the 
effect of obesity on cognitive functions, using the 
important related biomarkers to predict changes in 
cognitive functions, and to define better tools for 
diagnosis and follow up. In addition, two functional 
food in the form of dietary supplements were studied 
to end up with the most efficient in helping to control 
obesity and deterioration in cognitive functions in the 
middle aged obese women, as a preventive strategy 
to reduce the incidence of the full picture of dementia 
later in life.  
 
 
Materials, Methods and Subjects 
 
Raw Materials  
Whole meal naked barley grains (giza 129) 
was purchased from The Ministry of Agriculture. 
Wheat germ was purchased from the North Cairo Mills 
Company, Egypt. Turmeric (Curcuma longa) and 
ginger (Zingiber  officinale) were obtained from local 
herbal shop (Dokki, Egypt).  Skimmed milk, tomato 
sauce, corn oil, baking powder and salt were 
purchased from the local market. 
 
Preparation and Evaluation of the Bread  
Basic and modified formulas were prepared 
by mixing the barley flour with 5% turmeric powder 
(formula 1), or with 5% ginger powder (Formula 2), 
then with other ingredients according to table (1). 14.7 
ml of dextrose solution (5.93%) and a suitable amount 
of water were added according to AOAC [13] to be 
formed as Syrian bread. These formulas were baked 
in a special oven at 200 °C for about 15 minutes. 
Weight, volume, Specific volume, diameter, thickness 
and spread ratio of the bread were recorded. 
Table 1: Formula composition of Syrian bread (g/ 100g). 
Raw materials Formula 1 Formula 2 
Naked barley 60 60 
Wheat germ 15 15 
Turmeric 5 - 
Ginger - 5 
Skimmed  milk 10 10 
Tomato sauce 1.5 1.5 
Corn oil 5 5 
Baking powder 2 2 
Salt 1.5 1.5 
 
Analytical Methods 
Moisture, ash, fiber, protein and fat contents 
of two formulas of the Syrian bread were determined 
according to AOAC [13]. Individual elements (Ca, P, 
K, Na, Fe, Zn and Mg) in all samples were determined 
according to the method described by Chapman and 
Pratt [14]. Fatty acids, amino acids and polyphenols 
were determined using standard methods [15, 16]. 
 
Organoleptic Tests 
The two formulas of the Syrian bread were 
evaluated for color (20), flavor (20), taste (20), 
crispiness (20), appearance (20) and overall 
acceptability (100) according to the method described 
in AACC [17]. 
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Subjects 
Ninety six obese Egyptian women shared as 
volunteers in this study which lasted for 8 weeks, 
divided into two phases of four weeks each. The 
patients were divided into two groups: group (A); 50 
patients with a mean age of 46.04 ± 1.88 years and a 
mean BMI of 37.64 ± 1.11 kg/m², and group (B); 46 
patients with a mean age of 47.33 ± 2.23 years and a 
mean BMI of 34.83 ± 1.49 kg/m². The protocol of the 
study was approved by the National Research Center 
Ethics Committee. In addition, an informed consent 
was obtained from each volunteer. During the first 
phase, group (A) followed a low caloric balanced diet 
(1000-1200 Kcalories/day), supplemented by naked 
barley flour mixed with 5% turmeric powder that was 
baked  in the form of Syrian bread (Formula 1), two 
servings were consumed with breakfast (40 g) and 
one serving with dinner (20 g), instead of Baladi 
bread. Group (B) consumed another formula of the 
bread made from naked barley flour supplemented 
with 5% ginger powder (Formula 2), with the same 
instructions. Phase (2) lasted for 4 weeks in which the 
volunteers were following only the same low caloric 
balanced diet, where baladi bread replaced the Syrian 
bread supplying the same caloric content. The 
participants were monitored clinically, biochemically 
and cognitively throughout. 
 
Anthropometric Parameters and Blood 
Pressure Measurements 
Blood pressure was measured while they 
were sitting quietly for 5 minutes using a mercury 
sphygmomanometer, where the mean of three 
readings were recorded. Relevant anthropometric 
measurements were recorded including height, 
weight, waist (minimal waist) and hip circumferences 
using standard method [18]. Body fat (BF) as a 
percent from the body weight was measured by using 
Geratherm Body Fitness (B-5010), Germany. Waist to 
hip ratio (WHR) as minimal waist to hip 
circumferences in cm, and body mass index (BMI) as 
weight in relation to height (weight in kg/ height² in 
meter) were calculated. 
 
Blood Sampling and Biochemical Analysis 
Fasting blood samples (12 hours fasting) 
were drawn from the patients, before starting the 
regimen (basal sample), at the end of the first phase 
(mid sample) and lastly at the end of second phase 
(last sample). Blood samples were allowed to clot and 
the sera were separated. Fasting blood glucose (FBG) 
was determined on fresh sera using glucose oxidase 
method [19]; the remaining sera were stored at -70 C 
until used for further analysis. Serum total cholesterol 
(T.cholesterol), high density lipoprotein-cholesterol 
(HDL-C) and triglycerides (TG) were determined 
using; cholesterol proceed No 1010, Stanbio [20], 
HDL-C proceed No 0599 StanioLiquicolor [21] and 
triglycerides proceed No 2100 [22] (Enzymatic 
methods) respectively. Friedewald formula [23] was 
used to calculate low density lipoprotein-cholesterol 
(LDL-C); LDL-C = (Total Cholesterol) - (HDL-C) - 
(TG/5). Serum C-peptide was detected by enzyme 
Immunoassay Test Kit, catalogue no. E29-071, 
IMMUNOSPEC Corporation, Netherland [24].  
According to Li et al. [25], insulin resistance was 
expressed by modified homeostasis model 
assessment- insulin resistance (M.HOMA-IR); 
M.HOMA-IR = 1.5 + FBG (mg/dl) × fasting C-peptide 
(ng/ml)/ 2.800, in which insulin was replaced by C-
peptide, so as to be applied on diabetic patients using 
exogenous insulin. Ceramide kinase (CERK) enzyme 
concentration was detected by Human CERK ELISA 
kit, catalogue no. 201-12-3437, Sun Red Shanghai 
[26]. 
 
Dietary Recalls 
Collecting detailed data about nutritional 
habits and intake through 24hours- recall dietary 
history. Analysis of food items using World Food 
Dietary Assessment, (WFDAS), 1995, USA, University 
of California. 
 
Cognitive and Mental Evaluation 
Mini Mental State Examination (MMSE) was 
performed for evaluation of mental and cognitive 
status. Sleep quality, and the number of sleeping 
hours and their pattern were evaluated. Exposure to 
sun: time, duration and clothing. A scoring system of 3 
points scale was then put to present the degree of 
exposure and adequacy. General subjective life 
stresses, life pattern to evaluate general activity and 
history of exercising were recorded and put on the 3 
points scale [27].  
 
Statistical Analysis 
All values were expressed as mean± SE. Two 
tailed student’s t-test was used to compare the two 
groups. Correlation between the different parameters 
was tested by Pearson test. P values <0.05 were 
considered statistically significant. SPSS window 
software version 17.0 (SPSS Inc. Chicago, IL, USA, 
2008) was used. 
 
 
Results 
 
Table 2 summarizes the average of moisture, 
protein, fat, crude fiber and ash of the two formulas of 
the Syrian bread with either turmeric or ginger. 
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Table 2: Chemical composition of the two types of the Syrian 
bread supplements. 
Bread samples Moisture (%) Protein (%) Fat (%) Fiber (%) Ash (%) T. CHO (%) 
Formula 1 bread (1) 8.22 ± 0.22
b
 18.12 ± 0.65
b
 8.22 ± 0.29
b
 6.25 ± 0.13
a
 3.16 ± 0.19
a
 64.25 ± 0.74
a
 
Formula 2 9.11 ± 0.35
a
 20.5 ± 0.52
a
 8.92 ± 0.41
a
 5.95 ± 0.09
b
 3.25 ± 0.11
b
 61.38 ± 0.96
b
 
LSD at 0.05 0.82 1.013 0.026 0.22 0.086 1.032 
T. CHO: total carbohydrates. 
Data presented in Table 3 show the sensory 
evaluation of the two Syrian bread supplements as a 
function of replaced barley flour with turmeric or 
ginger. Regarding color, flavor, taste, crispiness, 
general appearance and overall acceptability, it could 
be noticed that significant differences between the two 
formulas. 
Table 3: Hunter color parameters of the two types of the Syrian 
bread supplements. 
Overall 
acceptability 
(100) 
Appearance 
(20) 
Crispness 
(20) 
Taste (20) Flavor (20) Color (20) 
Bread 
samples 
90.29 ± 0.65
a
 17.2
 
± 0.69
b
 17.22 ± 0.26
b
 17.5
 
± 0.1
 b
 18.17 ± 0.66
a
 18.2 ± 0.22
a
 Formula 1 
90.14 ± 0.62
b 
18.62 ± 0.58
a
 18.42 ± 0.39
a 
18.3
 
± 0.2
 a 
16.82 ± 0.57
b
 16.98 ± 0.35
b
 Formula 2 
0.122 1.013 1.052 1.12 1.025 0.96 LSD at .05 
 
 
Table 4 shows the mineral contents of the raw 
ingredients and the two types of bread. Adding wheat 
germ and either of the turmeric or the ginger to the 
two supplements enriched its mineral contents and 
raised most of their values. 
Table 4: Minerals level (mg/100g) in dry tested samples 
Serial 
No. 
Samples P K Ca Mg Na Fe Zn 
1 Barely 368.3 483.5  49.4 89.4 78.3 4.8 4.5 
2 Wheat germ 1126.1 1012. 51.6 323.7 36.7 14.5 21.1 
3 Turmeric 26.5 271.3 28.3 13.9 15.8 3.3 0.35 
4 Ginger 223.2 1879.4 72.4 231.1 32.5 21.8 3.9 
5 Formula (1) 637.1 533.7 48.3 146.0 55.8 8.1 8.7 
6 Formula (2) 723.6 612.5  59.7 157.6 60.6 6.9 7.5 
Formula 1 (5 %) turmeric; Formula 2 (5 %) ginger. 
 
Table 5 shows the phenolic compounds of the 
raw ingredients and the two types of bread. The final 
results showed that the two types of Syrian bread 
showed nearly equal values. 
Table 5: Total phenols contents of dry tested samples (mg/ 
100g). 
Serial No. Sample 
Total phenols 
(as tannins) 
1 Barely 5796.98 
2 Wheat germ 7530.57 
3 Turmeric 5471.14 
4 Ginger 7561.66 
5 Formula (1) 5338.3 
6 Formula (2) 5460.0 
 
Fig. 1-4 shows the amino and fatty acids 
pattern of the two types of the Syrian bread. They 
were high in glutamine, histidine, tyrosine, alanine and 
arginine amino acids. Ginger bread (formula 2) 
showed higher content of the omega -3 fatty acids. 
Table 6 shows the mean ± SE of the macro 
and micro nutrients of the habitual diet of the obese 
women and the three hypo-caloric regimens; with 
Baladi bread and with the two types of the Syrian 
bread. The habitual diet of the patients showed high 
rate of consumption of protein, fat and carbohydrate 
which reflected high caloric intake (123.52% of the 
RDA). The mean intake of vitamin A and D, and the 
mean mineral intake of calcium, iron and zinc were 
below the RDA. The three recommended regimens 
showed low caloric intake with sufficient protein, fat 
and carbohydrate, and better levels of the vitamins 
and the minerals. 
 
Figure 1: Amino acids content (mg/g) in Formula (1): Aspartic 
(14.9), Thereonine (1.7), Serene (6.0), Glutamic (53.4), Glycine 
(4.6), Alanine (27.9), Valine (2.4), Methionine (2.5), Isoleucine 
(14.0), Tyrosine (31.7), Phenylalanine (15.6), Histidine (38.0), 
Lysine(10.5), Arginine (22.9) and Proline (3.9). 
 
Figure 2: Amino acids content (mg/g) in Formula (2): Aspartic 
(28.7), Thereonine (5.1), Serene (9.3), Glutamic (38.0), Glycine 
(4.7), Alanine (21.7), Valine (7.3), Methionine (20.1), Isoleucine 
(54.3), Tyrosine (70.5), Phenylalanine (18.5), Histidine (7.7), Lysine 
(2.3), Arginine (20.5) and Proline (10.3). 
 
Figure 3: Relative area (%) of fatty acid contents in Formula (1): (a) 
palmitic acid (C16:0 , 14.8), (b) palmetoleic acid (C16:1, 4.4), (c) 
stearic acid (18:0, 27.24), (d) oleic acid (C18:1, 11.8), (e) linoleic 
acid (C18:2, 9.7) and (f) linolenic acid (C18:3, 6.2). 
 
Figure 4: Relative area (%) of fatty acid contents in Formula 2: (a) 
palmitic acid (C16:0, 8.7), (b) palmetoleic acid (C16:1, 3), (c) stearic 
acid (18:0, 0.5), (d) oleic acid (C18:1, 34.5), (e) linoleic acid (C18:2, 
18.7) and (f) linolenic acid (C18:3, 10.6). 
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Table 6: Mean ± SE & %RDA of macro and micronutrients of the habitual diet and the three types of dietary therapy among the 
obese women. 
RDA 
Diet with Ginger bread (formula 2) Diet with Turmeric bread (formula 1) Diet with Baladi Bread Habitual diet 
Nutrient intake Mean ± S E 
%RDS 
Mean ± S E 
%RDS 
Mean ± S E 
%RDS 
Mean ± S E 
%RDS 
2200 
901.02 ± 67.20 
40.96% 
904.28 ± 70.59 
41.10% 
974.25 ± 152.11 
44.28% 
2717.53 ± 235.01 
123.52% 
Energy (kcal) 
50 
53.05 ± 11.34 
106.10% 
52.23 ± 14.67 
104.46% 
52.63 ± 19.17 
105.26% 
91.23 ± 27.30 
182.46% 
Protein ( g) 
 27.18 ± 12.37 28.04 ± 13.20 30.17 ± 16.31 123.57 ± 37.08 Fat ( g) 
 111.05 ± 24.61 110.75 ± 28.71 123.05 ± 32.51 310.12 ± 60.96 Carbohydrates(g)  
 35.60 ± 7.84 35.47 ± 8.91 29.19 ± 10.02 18.83 ± 9.97 Dietary fiber (g) 
800 
778.51 ± 20.31 
97.31% 
775.31 ± 21.98 
96.91% 
771.54 ± 23.11 
96.44% 
598.12 ± 20.97 
74.77% 
Vit. A (µg) 
5 
3.75 ± 0.28 
75.00% 
3.78 ± 0.35 
75.60% 
3.61 ± 0.52 
72.20% 
2.16 ± 0.65 
43.20% 
Vit. D (µg) 
500 
309.78 ± 11.37 
61.96% 
320.89 ± 14.27 
64.18% 
385.20 ± 30.25 
77.04 
655.25 ± 50.30 
131.05% 
Sodium (mg) 
2000 
1630.71 ± 26.30 
81.54% 
1645.82 ± 30.69 
82.29% 
1638.89 ± 60.35 
81.94% 
3231.78 ± 45.50 
161.59% 
Potassium (mg) 
1000 
852.73 ± 27.32 
85.27% 
835.13 ± 26.91 
83.51% 
804.61 ± 36.25 
80.46% 
624.37 ± 70.61 
62.44% 
Calcium (mg) 
15 
11.26 ± 3.01 
75.07% 
11.30 ± 2.64 
75.33% 
11.20 ± 1.62 
74.67% 
7.35 ± 1.26 
49.00% 
Iron (mg) 
12 
10.22 ± 1.37 
85.17% 
10.19 ± 1.84 
84.92% 
9.76 ± 1.54 
81.33% 
8.49 ± 2.08 
70.75% 
Zinc (mg) 
 9.02 ± 1.39 9.03 ± 1.28 9.29 ± 2.39 41.6023 ± 13.59 SFAs ( g) 
 10.88 ± 1.94 10.95 ± 1.89 10.46 ± 2.14 37.3715 ± 11.75 MUFAs( g) 
 5.36 ± 1.87 5.39 ± 1.94 7.77 ± 2.58 34.89 ± 11.69 PUFAs ( g) 
 87.65 ± 3.46 87.35 ± 4.58 89.20 ± 11.74 390.58 ± 44.06 Cholesterol (mg) 
SFAs; Saturated Fatty acids; MUFAs: Mono-Unsaturated Fatty acids;  PUFA: Poly-Unsaturated Fatty acids. 
 
 
Table 7 shows the base line results of the 
mini mental state examination (MMSE) which evaluate 
cognitive functions. The results show that 16.7 % has 
mild cognitive impairment, 72.9 % has good mental 
functions with no signs of cognitive impairment, while 
10.4 % has excellent mental and cognitive functions. 
33.4 % had very low hours of sleep, 60.4 % get 
moderate sufficient hours of sleep, while 6.2% get 
more than average hours of sleep. Sleep quality is low 
in 27.1%, moderate in 31.3% and high in 41.6%. What 
is clear that exposure to sun and general activity is 
low in general, while stress is very high in more than 
50% of the sample. Moderate exercising is practiced 
by 56.3 % of the sample, low exercising in 31.2% and 
high exercising in 12.5%. The percent distribution of 
the sample as regard the MMSE, sleeping quality, 
general activity, exercising and exposure to sun were 
improved by the end of the intervention, contrary to 
the issue of stress which was still a challenge. 
Table 7: Cognitive variables in percentage at the basal visit and 
after intervention 
Variable Score (1) 
% 
Basal 
Score (1) 
% 
Last 
Score (2) 
% 
Basal 
Score (2) 
% 
Last 
Score (3) 
% 
Basal 
Score (3) 
% 
Last 
MMSE 
Sleeping hours 
Sleeping quality 
Exposure to sun 
Stress 
General activity 
Exercising 
16.7 
33.4 
27.1 
41.6 
8.3 
42.0 
31.2 
13.3 
33.4 
24.9 
40.7 
7.9 
30.0 
28.0 
72.9 
60.4 
31.3 
31.3 
36.6 
33.0 
56.3 
76.2 
60.2 
33.3 
31.2 
39.2 
40.0 
58.5 
10.4 
6.2 
41.6 
27.1 
52.1 
25.0 
12.5 
10.5 
6.4 
41.8 
28.1 
52.9 
30.0 
13.5 
MMSE:   22-25 =Score 1, 26-28=Score 2, 29= Score 3;  Sleeping hours: 4-5 =Score 1, 6-8 
= Score 2, 9-10 = Score3. Exposure to sun, Sleep quality, Stress, General activity, 
Exercising:  1=low       2=medium      3 =high  
 
 
Table 8 shows the mean± SE of age, 
anthropometric and blood pressure measurements of 
the two groups at the start of the study (basal visit) 
and at the end of the two phases of regimen (mid and 
last visits). All the anthropometric measurements 
decreased significantly in both groups at p<0.05-0.01 
at the mid and the last visits, except the BMI and %BF 
in group (A) which showed numerical decreases at the 
mid visit, while weight and BMI showed significant 
increases at the last visit. Both of systolic blood 
pressure in group (A), and diastolic blood pressure in 
group (B) showed significant decrease at the last visit 
only. 
Table (9) shows the mean± SE of the different 
investigated biochemical parameters. At the end of 
phase (1), in spite of the slight elevation in the level of 
the FBG at the start of the study, as the diabetic 
participants were under medical treatment, yet the 
mean level of the FBG decreased significantly in both 
groups. The lipid profile disorders that were detected 
at the basal examination were improved significantly 
in both groups.  Non- HDL-C is an important marker in 
such condition. C-peptide concentration and 
M.HOMA-IR values decreased significantly in both 
groups at p<0.05-0.01. The CERK enzyme 
concentration increased significantly in group (A), and 
numerically in group (B). At the last visit, the levels of 
these parameters increased with different ranges in 
both groups, while HDL-C and CERK concentrations 
decreased. 
 
Discussion 
  The data obtained in this study concerning 
chemical composition, color attributes and sensory 
evaluation of Syrian bread supplements showed that 
the protein, fat, ash and total carbohydrate of Syrian 
bread produced from barley flour with ginger (formula 
2) were higher than Syrian bread produced from 
barley flour with turmeric (formula1); however the fiber 
content of formula 1 was higher than that of formula 2. 
Therefore,  it  could  be  concluded  that  barley  flour  
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Table 8: Mean ± SE of age, anthropometric parameters and blood pressure among obese subjects at the three visits. 
Group (B) 
n= 46 
Group (A)  
n= 50 
 
Parameters  
Last Mid Basal Last Mid Basal  
  47.33 ± 2.23   46.04 ± 1.88 Ages (year) 
  157.50 ± 1.07   159.30 ± 1.17 Height (cm) 
82.91 ± 3.64
**d
 83.25 ± 3.43
**c
 86.53 ± 3.55 87.46 ± 2.37
**b
 86.47 ± 3.46
* a
 94.79 ± 2.97 Weight (kg) 
33.52 ± 1.46
**d
 33.49 ± 1.48
**c
 34.83 ± 1.48 35.37 ± 0.88
**b
 34.38 ± 1.36 37.64 ± 1.11 BMI (kg/m² ) 
41.40 ± 1.90 42.65 ± 1.63 43.02 ± 1.68 45.51 ± 1.42 46.32 ± 1.44 47.34 ± 0.92 % BF 
83.44 ± 2.88
**d
 86.19 ± 2.56
**c
 91.89 ± 2.80 86.64 ± 2.29
**b
 91.97 ± 2.16
**a
 98.79 ± 2.16 Waist (cm) 
107.47 ± 3.19
**d
 109.75 ± 2.72
**c
 115.92 ± 2.76 110.54 ± 3.29
**b
 115.08 ± 2.67
**a
 122.00 ± 2.06 Abdominal II (cm) 
110.03 ± 2.97
**d
 112.23 ± 2.71
**c
 117.47 ± 2.85 113.66 ± 2.53
**b
 117.25 ± 1.92
**a
 122.53 ± 1.99 Hip (cm) 
0.75 ± 0.01 0.76 ± 0.01
**c
 0.78 ± 0.01 0.76 ± 0.018
**b
 0.78 ± 0.013
**a
 0.81 ± 0.014 WHR (cm/cm) 
123.21 ± 2.26 122.94 ± 1.70 124.71 ± 3.32 118.21 ± 3.08
*b
 121.11 ± 2.76 121.11 ± 2.96 SBP (mmHg) 
72.31 ± 2.01
*d
 73.53 ± 1.70 74.12 ± 1.67 71.42 ± 2.53
*b
 71.11 ± 1.96 71.11 ± 2.31 DBP (mmHg) 
BMI: Body mass index; BF: Body fat; WHR: Waist to hip ratio; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; a: Basal vs. Mid; b: Mid vs. Last    in Group A; c: Basal 
vs. Mid; d: Mid vs. Last    in   Group B; *P < 0.05; **P < 0.01. 
 
 
could be mixed with either turmeric or ginger without 
drastic effect on the technological quality and sensory 
properties of Syrian bread.  Moreover, higher nutritive 
values of this Syrian bread are achieved. 
Supplementation with skimmed milk, corn oil, turmeric 
and ginger improved their contents of protein, fat, 
ﬁber, ash, β glucan and minerals. Such findings are 
in-agreement with several previous studies [28-31].  
Nearly similar significant decreases in the 
mean levels of most of the anthropometric 
measurements of the two groups were reported at 
p<0.05 & 0.01. After omitting the supplements, most 
of the anthropometric measurements still decreased in 
both groups, yet significant increase was reported in 
group (A) only in the mean weight and BMI, this might 
be attributed to an increase in the muscle mass, as a 
decrease in the mean value of the %BF was reported.  
Small variations in the recorded values of the 
blood pressure were observed. Most of these values 
were found within the normal ranges as most of the 
hypertensive patients were under medical treatment; 
however both significant and numerical decreases in 
some of these values were reported in the different 
phases. The low caloric value and the bioactive 
components of the prescribed dietary therapy like 
fiber, phenolic compounds, omega-3 fatty acids and 
potassium might be the contributing factors that 
influenced the body weight and blood pressure.  
The data of this study demonstrated an 
important healthy beneficial effect of both types of 
bread on the biochemical parameters which was high 
in its value when compared to their effect on the 
anthropometric measurements.  At the last visit, the 
mean serum concentrations of the FBG, TG and the 
non-HDL-C significantly increased in group (A) 
compared to the values obtained at the mid visit, 
where a further increase in the mean level of the TG 
(33.6%) was reported. Furthermore, the mean 
concentration of the HDL-C decreased numerically in 
the same group. In group (B) the mean concentration 
of the FBG and most of lipid parameters increased 
numerically. Our data are in agreement with Shatwan 
et al. [32] who stated that consuming diets containing 
either cinnamon, barley, or their combinations 
regulate blood glucose, lipid profile, and adipose 
tissue hormones in type 2 diabetic rats. The 
mechanism that explains the link between diabetes 
and cognitive impairment involve vascular, metabolic, 
and inflammatory/ oxidative processes [33]. In 
addition, in this study improving of the C-peptide 
concentration, the M.HOMA-IR values and the 
cognitive functions after the supplemented dietary 
intervention might add a further support to this 
suggested link. 
Ceramides are lipid signaling molecules that 
cause cytotoxicity and cell death mediated by insulin 
resistance, inflammation, and endoplasmic reticulum 
(ER) stress. Concomitantly, insulin resistance 
dysregulates lipid metabolism, which promotes the 
complications of the ceramide accumulation.  The 
toxic ceramides generated external to the CNS, as the 
liver, are released into the peripheral blood, and are 
subsequently transmitted across the blood-brain 
barrier to the brain where they induce brain insulin 
resistance, inflammation, and cell death [9].  
 
 
 
Table 9: Mean± SE of Biochemical parameters of the two groups at the basal and the end of the two phases of the dietary therapy. 
 
 
Biochemical 
Parameters 
Group A (no.=50) Group B (no.=46) 
Basal Mid Last Basal Mid Last 
FBG (mg/dl) 
TG (mg/dl) 
VLDL-C (mg/dl) 
T. cholest.(mg/dl) 
LDL-C (mg/dl) 
HDL-C (mg/dl) 
Non-HDL (mg/dl) 
Risk factor 
C-peptide (ng/ml) 
M. HOMA-IR 
CERK (ng/ml) 
112.87 ± 4.66 
139.28 ± 13.10 
27.86 ± 2.62 
243.54 ± 10.18 
167.74 ± 10.16 
47.93 ± 1.53 
195.61 ± 10.84 
5.17 ± 0.29 
4.93 ± 0.97 
1.69 ± 0.04 
17.27 ± 3.80 
99.53 ± 3.89**
a
 
88.86 ± 8.27**
a
 
17.77 ± 1.65**
a
 
185.32 ± 6.62**
a
 
113.21 ± 7.55**
a
 
54.33 ± 1.74**
a
 
130.98 ± 7.16**
a
 
3.47 ± 0.18**
a
 
3.72 ± 0.85*
a
 
1.63 ± 0.03**
a
 
18.02 ± 3.95*
a
 
114.02 ± 4.84**
b
 
118.69 ± 7.91**
b
 
23.74 ± 1.58**
b
 
205.09 ± 10.53 
129.37 ± 10.44 
51.98 ± 1.53 
153.11 ± 10.88*
b
 
3.99 ± 0.26*
b
 
4.05 ± 0.91*
b
 
1.67 ± 0.04**
b
 
17.67 ± 4.56**
b
 
119.58 ± 5.48 
135.24 ± 9.30 
27.05 ± 1.86 
217.01 ± 9.05 
143.56 ± 8.75 
46.39 ± 1.38 
170.61 ± 8.93 
4.73 ± 0.22 
5.07 ± 0.74 
1.72 ± 0.04 
15.51 ± 3.50 
103.19 ± 4.77**
a
 
103.87 ± 7.37**
a
 
20.77 ± 1.47**
a
 
180.57 ± 7.31**
a
 
107.99 ± 7.87**
a
 
51.81 ± 1.29**
a
 
128.76 ± 7.87**
a
 
3.54 ± 0.18**
a
 
3.59±0.47**
a
 
1.64 ± 0.02**
a
 
16.34 ± 3.37 
106.38 ± 4.20 
102.09 ± 5.41 
20.42 ± 1.08 
183.72 ± 5.99 
112.05 ± 5.67 
51.25 ± 1.64 
132.47 ± 6.07 
3.63 ± 0.15 
3.72 ± 0.56 
1.65 ± 0.03 
14.62 ± 3.09 
FBG: Fasting blood glucose; TG: Triglycerides; VLDL-C: Very low density lipoprotein cholesterol; T. cholest.: Total cholesterol; LDL-C: Low density lipoprotein cholesterol; HDL-C: High 
density lipoprotein cholesterol; M.HOMA-IR: Modified homeostatic model assessment of insulin resistance; CERK: Ceramide kinase; a: Basal vs. Mid; b: Mid vs. Last; *P<0.05; **P<0.01. 
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Ceramide is involved in the generation of 
insulin resistance, so it is important to prevent its 
elevation in human body via increasing the activity of 
CERK enzyme that converts the ceramide to C1P via 
its phosphorylation [34]. C1P is a sphingolipid 
metabolite that has been implicated in membrane 
fusion of brain synaptic vesicles and neutrophil 
phagolysosome formation.  C1P is a key regulator of 
cell growth and survival, it stimulates DNA synthesis 
and cell division, and it is a potent inhibitor of 
apoptosis [35]. 
The data of this study showed improvement in 
the serum level of the enzyme CERK after using of 
the dietary supplements (mid visit), that improved the 
metabolic profiles including insulin resistance. In this 
context, the biochemical response was more sensitive 
than the oral tests in reflecting the improvement of the 
brain physiology. This is because the results of the 
oral tests were alike in both the mid and last visits of 
both phases. Many studies have shown that C1P is 
important for membrane biology and for the regulation 
of membrane-bound proteins, and that the CERK 
enzyme has appeared to be tightly regulated as it is 
pivotal in controlling both the ceramide level and the 
production of C1P [11].  
In conclusion, the data obtained in this study 
give further support to the relation between the 
prevalence of obesity and its complication in the 
deterioration of the cognitive functions in middle aged 
women. In addition, using dietary therapy supported 
by special formulas which contain active ingredients 
succeeded in reducing weight and improving both the 
metabolic profile and the cognitive functions thus 
alleviating the burden of cognitive impairment and 
dementia in the future. 
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